Información de la revista
Lo más leído
796537
Skin manifestations of liver diseasesA. Koulaouzidis;, S. Bhat;, J. Moschos
Ann Hepatol. 2007;6:181-4
796537
Open access
132987
COVID-19 and the liver: What do we know after six months of the pandemic?Nora A. Fierro
Ann Hepatol. 2020;19:590-1
132987
Open access
Artículo abierto
78115
Effects of systemic chemotherapy on the liverGiuliano Ramadori, Silke Cameron
Ann Hepatol. 2010;9:133-43
78115
Open access
60234
Anti-hepatitis B virus activity of food nutrients and potential mechanisms of actionAlexis Jose-Abrego, Ingrid Rivera-Iñiguez, Luis A. Torres-Reyes, Sonia Roman
Ann Hepatol. 2023;28:100766
60234
Acceso a texto completo
56941
Patterns of viral load in chronic hepatitis B patients in Brazil and their association with ALT levels and HBeAg statusMarcelo Eidi Nita, Nelson Gaburo, Hugo Cheinquer, Gilbert L’ltalien, Evaldo Stanislau Affonso de Araujo, Patricia Mantilla, Nancy Cure-Bolt, Paulo A. Lotufo
Ann Hepatol. 2009;8:339-45
56941
Open access
56351
Diagnosis of liver nodules within and outside screening programsMassimo Colombo
Ann Hepatol. 2015;14:304-9
56351
Open access
52217
Bile Acid PhysiologyAgostino Di Ciaula, Gabriella Garruti, Raquel Lunardi Baccetto, Emilio Molina-Molina, Leonilde Bonfrate, David Q.-H. Wang, Piero Portincasa
Ann Hepatol. 2017;16 Supl 1:S4-S14
52217
Open access
34071
Guidelines for the diagnosis and treatment of extrahepatic portal vein obstruction (EHPVO) in childrenJudith Flores-Calderón, Segundo Morán-Villota, Solange-Heller Rouassant, Jesús Nares-Cisneros, Flora Zárate-Mondragón, Beatriz González-Ortiz, José Antonio Chávez-Barrera, Rodrigo Vázquez-Frías, ... Gustavo Varela-Fascinetto
Ann Hepatol. 2013;12 Supl 1:S3-S24
34071
Open access
33876
Current concepts in acute liver failureMaximiliano Rovegno, Magdalena Vera, Alex Ruiz, Carlos Benítez
Ann Hepatol. 2019;18:543-52
33876
Open access
33684
Shark liver oil: hidden dangersSerta Kilincalp, Murat Deveci, Omer Basar, Fuat Ekiz, Sahin Coban, Osman Yuksel
Ann Hepatol. 2012;11:728-30
33684
Open access
33317
Treatment of hyperferritinemiaMelanie D. Beaton, Paul C. Adams
Ann Hepatol. 2012;11:294-300
33317
Open access
32692
Transmission routes of hepatitis C virus infectionEduardo Zumaeta Villena
Ann Hepatol. 2006;5 Supl 1:S12-4
32692
Open access
30483
Ocular manifestations of liver disease in children: Clinical aspects and implicationsDurga Prasad, Arpita Bhriguvanshi
Ann Hepatol. 2020;19:608-13
30483
Open access
30258
Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol TransportHelen H. Wang, Gabriella Garruti, Min Liu, Piero Portincasa, David Q.-H. Wang
Ann Hepatol. 2017;16 Supl 1:S27-42
30258
Open access
27960
Beta blockers in portal hypertension. Are they really a good option?Eric López-Méndez, Misael Uribe
Ann Hepatol. 2006;5:86-91
27960
Open access
27100
Hepatic HydrothoraxYong Lv, Guohong Han, Daiming Fan
Ann Hepatol. 2018;17:33-46
27100
Open access
26453
The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver diseaseDaniel Iluz-Freundlich, Manna Zhang, Julia Uhanova, Gerald Y. Minuk
Ann Hepatol. 2020;19:204-8
26453
Open access
25516
Multiple Biliary Hamartomas, The ‘‘Von Meyenburg Complexes’’Joel O. Jáquez-Quintana, Erick A. Reyes-Cabello, Francisco J. Bosques-Padilla
Ann Hepatol. 2017;16:812-3
25516
Open access
22732
Anti-cancer effects of blue-green alga Spirulina platensis, a natural source of bilirubin-like tetrapyrrolic compoundsRenata Koníčková, Kateřina Vaňková, Jana Vaníková, Katerina Vánová, Lucie Muchová, Iva Subhanová, Marie Zadinová, Jaroslav Zelenka, ... Libor Vítek
Ann Hepatol. 2014;13:273-83
22732
Open access
21924
Post-liver transplantation medical complicationsRosalba Moreno, Marina Berenguer
Ann Hepatol. 2006;5:77-85
21924
Open access